Advertising biomedical devices, pharma products and medical services directly to consumers is a $6 billion per year market in the US. Some medical professionals and payors argue that it's a bad idea, even proposing that it must be legally banned, while others argue that it is highly beneficial to create well-informed consumers. Which one is it? Is it good or bad for consumers? For manufacturers? For the healthcare system? For providers?
We'll examine these multi-billion questions with Clay Wilemon, CEO of DevicePharm, a marketing strategy and integrated marketing solutions company that specializes in serving medical device, biotech, pharmaceutical, and life-sciences companies. Clay has been doing this for over 25 years, which gives him unique insights to cover the topic of this month's meeting.
Generously sponsored by
About LAVA Healthcare
No one disputes that the U.S. healthcare system is a mess that has been deteriorating for decades. Many argue that increasing legislation and regulation will worsen the problem, others argue its the best solution.
LAVA Healthcare is an ongoing conversation about how we might fix the mess applying innovation across a wide range of dimensions including technology, business models, patient involvement, offshore outsourcing, and training programs.
The main goal is to foster innovation, while allowing our community to learn, be inspired, make valuable new business relationships and re-establish old ones. And perhaps even perhaps even influence public policy.
Who should participate? Everyone with an interest in the U.S. healthcare system such as technologists, life-sciences professionals and vendors, medical practitioners, healthcare providers, policy makers, and consultants of all types.
LAVA Healthcare operates with monthly meetings, a blog, and a LinkedIn group.
Each meeting features a presentations by one a healthcare innovator or investor who believes his/her ideas will have significant effects on the cost and quality of our healthcare system. Following the short presentation by the innovator, the audience criticizes, applauds, grinds, brainstorms, embellishes, refines, and pokes holes into the idea. There are no panelists or talking heads at the front of the room. The group leads the conversation: Is it a large problem? A small problem? A problem at all? Why is it a problem? What can be done about it? The conversation is directed and textured by the experience and knowledge of every member of the audience who poses questions, tells stories, and proposes answers.
Meetings are governed by five simple rules:
- Have fun, explore new and old ideas, make new friends and reconnect with old ones.
- Nothing is off topic as long as its about healthcare.
- No talking-head lectures: Everyone is a panelist.
- No preset course: The group leads the conversation.
- Self-promotions and sermons instantly lose the floor at moderator's sole discretion.